Castaigne A - Search Results

1

[Clinical evaluation: from intermediate to surrogate criteria].

Boissel JP, Perret L, Bouvenot G, Castaigne A, Gérard-Coué MJ, Maillère P, Mismetti P, Vray M. Boissel JP, et al. Among authors: castaigne a. Therapie. 1997 Jul-Aug;52(4):281-5. Therapie. 1997. PMID: 9437878 French.

2

Ventricular fibrillation following administration of thrombolytic treatment. The EMIP experience. European Myocardial Infarction Project.

Boissel JP, Castaigne A, Mercier C, Lion L, Leizorovicz A. Boissel JP, et al. Among authors: castaigne a. Eur Heart J. 1996 Feb;17(2):213-21. doi: 10.1093/oxfordjournals.eurheartj.a014837. Eur Heart J. 1996. PMID: 8732374 Clinical Trial.

3

[Methodologic and clinical lessons of large-scale trials of thrombolytic agents].

Beaufils P, Boissel JP, Castaigne A, Cohen-Solal A, Slama M, Spriet A. Beaufils P, et al. Among authors: castaigne a. Arch Mal Coeur Vaiss. 1989 Oct;82 Spec No 3:35-41. Arch Mal Coeur Vaiss. 1989. PMID: 2512886 Clinical Trial. French. No abstract available.

4

[The place of a new drug in the therapeutic strategy].

Castaigne A, Goehrs JM, Ravoire S. Castaigne A, et al. Therapie. 1999 Jul-Aug;54(4):463-70. Therapie. 1999. PMID: 10667112 Review. French.

5

[Importance of meta-analysis in cardiology].

Castaigne A. Castaigne A. Therapie. 1997 Jan-Feb;52(1):9-11. Therapie. 1997. PMID: 9183917 French. No abstract available.

6

[Renin-angiotensin-aldosterone system and heart failure: therapeutic aspects].

Castaigne A, Bénacéraff S. Castaigne A, et al. Therapie. 1998 May-Jun;53(3):285-9. Therapie. 1998. PMID: 9773128 Review. French.

7

[Substitution criteria in therapeutic trials].

Castaigne A. Castaigne A. Rev Prat. 1994 Oct 15;44(16):2129-31. Rev Prat. 1994. PMID: 7984908 French. No abstract available.

8

[Heart and brain: are the risk factors the same? Are the results of primary and secondary trials comparable?].

Castaigne A, Haziza F, Lopes-Darmon ME. Castaigne A, et al. Arch Mal Coeur Vaiss. 1998 Oct;91 Spec No 5:59-63. Arch Mal Coeur Vaiss. 1998. PMID: 9833081 French.

9

[Methods for evaluating thrombolytic drugs].

Castaigne A, Duval-Moulin AM, Dubois-Randé JL, Merlet P. Castaigne A, et al. Arch Mal Coeur Vaiss. 1990 Feb;83 Spec No 1:9-14. Arch Mal Coeur Vaiss. 1990. PMID: 2108647 French.

10

The influence of molsidomine on infarct size: an acute post-infarction pilot study with 303 patients.

Beaufils P, Kolsky H, Haiat R, Castaigne A, Slama R. Beaufils P, et al. Among authors: castaigne a. Cardiovasc Drugs Ther. 1988 May;2(1):127-32. doi: 10.1007/BF00054263. Cardiovasc Drugs Ther. 1988. PMID: 3154688 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters